BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 3)
Image/CDC

Endari approved for treatment of sickle cell disease

By

The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood...

Neisseria gonorrhoeae/CDC

Gonorrhea: Drug resistance growing, ‘May just be the tip of the iceberg’

By

Data from 77 countries show that antibiotic resistance is making gonorrhea – a common sexually-transmitted infection – much harder, and sometimes impossible, to treat, according to a World Health Organization...

Staphylococcus aureus /CDC

Antibiotics effective for treatment of simple abscesses: Study

By

New multicenter research, which included Vanderbilt University Medical Center investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph)...

Middle East Respiratory Syndrome Coronavirus

New antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS

By

A multi-institutional team of investigators reported this week in Science Translational Medicine on a new antiviral drug candidate that inhibits a broad range of coronaviruses, including the SARS and...

Image/Profounda

Balamuthia: Profounda receives Orphan Drug Designation to use miltefosine for treatment

By

Orlando-based specialty pharmaceutical company, Profounda announced it has received the US Food and Drug Administration’s Orphan Drug Designation for the use of Impavido (miltefosine) to treat Granulomatous...

A study by University of Michigan Kellogg Eye Center shows 60 percent of pink eye patients get antibiotic eye drops, but they are seldom necessary. Image/Michigan Medicine/Manifest

Many ‘pink eye’ infections treated unnecessarily with antibiotics: Study

By

A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment. About 60 percent of patients nationwide are prescribed antibiotic eye drops, even though antibiotics...

Staphylococcus aureus /CDC

FDA approves new fluoroquinolone antibiotic, Baxdela

By

Melinta Therapeutics announced Monday that the U.S. Food and Drug Administration (FDA) has approved Baxdela™ (delafloxacin), indicated in adults for the treatment of acute bacterial skin and skin structure...

Pseudouridimycin and Rifampin Image/David Degen and Richard H. Ebright (Rutgers University)

Pseudouridimycin: A new antibiotic effective against drug-resistant bacteria

By

Scientists from Rutgers University-New Brunswick, the biotechnology company NAICONS Srl., and elsewhere have discovered a new antibiotic effective against drug-resistant bacteria: pseudouridimycin. The...

Actinomycetes is in a plate Image/DTU/DTU Biosustain

Superbugs: Some get their resistance genes in a complex process involving bacterial ‘sex’

By

To win the war against antibiotic resistant super bugs, scientists seek to find the origin of resistance genes. Further, they try to identify how the genes are introduced to disease-causing bacteria –...

Mature Plasmodium vivax schizont/CDC

Malaria drug, tafenoquine, show positive results from two phase III studies

By

GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced positive results from two phase III studies of tafenoquine, an investigational 8-aminoquinoline, for the prevention of relapse...